CR Q4 2025 Earnings Call Summary

Crane Company Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

Adjusted EPS: $1.53, up 21% year-over-year.
Core Sales Growth: 5.4% for Q4, with full-year adjusted EPS increasing by 24%.
Sales by Segment:
- Aerospace & Advanced Technologies (AAT): $272 million in sales, up 15% year-over-year.
- Process Flow Technologies (PFT): $309 million, flat compared to the previous year.
Adjusted Operating Profit: Increased by 16%, driven by higher productivity and favorable pricing.
Core FX-neutral backlog: Up 14% year-over-year, indicating strong demand.
Net Leverage: 1.1x post-acquisitions, increased to 1.4x after closing on additional acquisitions.

2. Strategic Updates and Business Highlights

Acquisitions: Completed the purchase of Druck, Panametrics, Reuter-Stokes, and optek-Danulat, enhancing Crane's capabilities in various sectors, including nuclear and biopharma.
Integration Progress: Integration of new acquisitions is underway, with expectations of slight accretion to earnings in 2026.
Leadership Transition: Alex Alcala will succeed Max Mitchell as CEO on April 27, 2026, with Mitchell transitioning to Executive Chairman.
Market Positioning: AAT segment is expected to outperform its markets, driven by strong backlogs and ongoing demand in aerospace and defense sectors.

3. Forward Guidance and Outlook

2026 Adjusted EPS Guidance: Projected between $6.55 to $6.75, reflecting a 10% growth at the midpoint.
Core Sales Growth Expectations: For 2026, AAT is expected to grow at the high end of 4% to 6%, while PFT is anticipated to be flat to low single digits.
Margin Expectations: Anticipated core operating leverage of 30% to 40% for both segments, with initial dilution expected from new acquisitions.

4. Bad News, Challenges, or Points of Concern

PFT Segment Weakness: Core sales declined by 1.5% due to sluggish demand in the chemical market, with expectations of continued softness.
Insurance Recoveries: A one-time benefit of $0.16 per share from insurance recoveries in 2025 will not repeat in 2026, creating a headwind for year-over-year comparisons.
Integration Costs: There will be costs associated with integrating new acquisitions, which may impact near-term financial results.

5. Notable Q&A Insights

Pricing Opportunities: Management expressed optimism about pricing improvements in the newly acquired businesses, particularly Druck, with expectations for better pricing strategies in the coming years.
Government Shutdown Impact: No significant impact on orders or funding from the recent government shutdown, although some military program timelines may be affected.
Future M&A Activity: The company remains open to further acquisitions, with a strong pipeline of potential targets, although no immediate deals are anticipated in Q1 2026.
Market Conditions: While the chemical sector remains weak, growth is expected in pharmaceuticals and cryogenics, with a cautious outlook for the overall PFT segment.

This summary encapsulates the key takeaways from Crane Company's Q4 2025 earnings call, highlighting financial performance, strategic initiatives, and future outlook while addressing potential challenges.

CR — Crane Company